Product Information |
DR-XY48407_PI_01.pdf
|
Registration Number |
DR-XY48407
|
Generic Name |
Indacaterol Acetate + Glycopyrronium Bromide + Mometasone Furoate
|
Brand Name |
Enerzair Breezhaler
|
Dosage Strength |
150mcg/50mcg/80mcg
|
Dosage Form |
Powder for inhalation in Hard capsules
|
Classification |
Prescription Drug (RX)
|
Pharmacologic Category |
Selective Beta-2 adrenoreceptor Agonist/
Anticholinergic/ Corticosteroid
|
Packaging |
PA/AL/PVC-PET/AL Blister Pack x 10's (Box of 10's + 1 Inhaler) (Box of 30's + 1 Inhaler)
|
Manufacturer |
Novartis Pharma Stein AG
|
Country of Origin |
Switzerland
|
Trader |
N/A
|
Importer |
Novartis Healthcare Philippines, Inc.
|
Distributor |
Novartis Healthcare Philippines, Inc.
|
Application Type |
Monitored Release
|
Issuance Date |
07 October 2022
|
Expiry Date |
07 October 2025
|